Logo image of PITA

HERAMBA ELECTRIC PLC (PITA) Stock Fundamental Analysis

NASDAQ:PITA - Nasdaq - IE000DKOX1A4 - Common Stock - Currency: USD

0.2333  -0.01 (-2.79%)

After market: 0.159 -0.07 (-31.85%)

Fundamental Rating

1

Taking everything into account, PITA scores 1 out of 10 in our fundamental rating. PITA was compared to 93 industry peers in the Electrical Equipment industry. PITA may be in some trouble as it scores bad on both profitability and health. PITA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PITA has reported negative net income.
PITA had a negative operating cash flow in the past year.
PITA Yearly Net Income VS EBIT VS OCF VS FCFPITA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 0 5M 10M

1.2 Ratios

PITA has a better Return On Assets (-3.78%) than 62.89% of its industry peers.
PITA's Return On Equity of -4.76% is fine compared to the rest of the industry. PITA outperforms 64.95% of its industry peers.
Industry RankSector Rank
ROA -3.78%
ROE -4.76%
ROIC N/A
ROA(3y)-38.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PITA Yearly ROA, ROE, ROICPITA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 0 50 -50 100 -100

1.3 Margins

PITA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PITA Yearly Profit, Operating, Gross MarginsPITA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023

1

2. Health

2.1 Basic Checks

The number of shares outstanding for PITA has been increased compared to 1 year ago.
The debt/assets ratio for PITA is higher compared to a year ago.
PITA Yearly Shares OutstandingPITA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
PITA Yearly Total Debt VS Total AssetsPITA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

PITA has an Altman-Z score of -0.13. This is a bad value and indicates that PITA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.13, PITA perfoms like the industry average, outperforming 48.45% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that PITA is not too dependend on debt financing.
PITA has a Debt to Equity ratio of 0.01. This is in the better half of the industry: PITA outperforms 78.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.13
ROIC/WACCN/A
WACCN/A
PITA Yearly LT Debt VS Equity VS FCFPITA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

PITA has a Current Ratio of 0.00. This is a bad value and indicates that PITA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.00, PITA is doing worse than 96.91% of the companies in the same industry.
A Quick Ratio of 0.00 indicates that PITA may have some problems paying its short term obligations.
The Quick ratio of PITA (0.00) is worse than 96.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
PITA Yearly Current Assets VS Current LiabilitesPITA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

PITA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -147.14%.
EPS 1Y (TTM)-147.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-509%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

PITA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PITA Price Earnings VS Forward Price EarningsPITA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PITA Per share dataPITA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PITA!.
Industry RankSector Rank
Dividend Yield N/A

HERAMBA ELECTRIC PLC

NASDAQ:PITA (4/28/2025, 8:00:00 PM)

After market: 0.159 -0.07 (-31.85%)

0.2333

-0.01 (-2.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)08-01 2025-08-01
Inst Owners1.65%
Inst Owner ChangeN/A
Ins Owners1.43%
Ins Owner ChangeN/A
Market Cap11.09M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS2.55
TBVpS2.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.78%
ROE -4.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -0.13
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-509%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-278.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.32%
OCF growth 3YN/A
OCF growth 5YN/A